CIK 0001477449
- Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043705970
- Phone
- +1 203-635-2002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Grant or award · Restricted Stock Units | +10,363 | 10,363 | ||
| 2019-03-04 | Verstraete Stephany Chief Marketing Officer | Exercise or conversion | +3,169 | 5,094 | ||
| 2019-03-04 | Verstraete Stephany Chief Marketing Officer | Shares withheld for taxes | −1,035 | $67.55 | $70K | 4,059 |
| 2019-03-04 | Verstraete Stephany Chief Marketing Officer | Exercise or conversion · Restricted Stock Units | −3,169 | 6,338 | ||
| 2019-03-04 | Verstraete Stephany Chief Marketing Officer | Grant or award · Restricted Stock Units | +11,103 | 11,103 | ||
| 2019-03-04 | Cappucci Gabriel R. Senior VP, Controller and CAO | Exercise or conversion | +1,767 | 1,767 | ||
| 2019-03-04 | Cappucci Gabriel R. Senior VP, Controller and CAO | Shares withheld for taxes | −538 | $67.55 | $36K | 1,229 |
| 2019-03-04 | Cappucci Gabriel R. Senior VP, Controller and CAO | Exercise or conversion · Restricted Stock Units | −1,767 | 3,533 | ||
| 2019-03-04 | Cappucci Gabriel R. Senior VP, Controller and CAO | Grant or award · Restricted Stock Units | +4,441 | 4,441 | ||
| 2019-03-04 | Levy Lewis Chief Medical Officer | Exercise or conversion | +2,881 | 5,352 | ||
| 2019-03-04 | Levy Lewis Chief Medical Officer | Shares withheld for taxes | −972 | $67.55 | $66K | 4,380 |
| 2019-03-04 | Levy Lewis Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −2,881 | 5,762 | ||
| 2019-03-04 | Levy Lewis Chief Medical Officer | Grant or award · Restricted Stock Units | +7,402 | 7,402 | ||
| 2019-03-04 | GOREVIC JASON N Chief Executive Officer | Exercise or conversion | +13,281 | 617,000 | ||
| 2019-03-04 | GOREVIC JASON N Chief Executive Officer | Grant or award | +13,944 | 630,944 | ||
| 2019-03-04 | GOREVIC JASON N Chief Executive Officer | Shares withheld for taxes | −13,060 | $67.55 | $882K | 617,884 |
| 2019-03-04 | GOREVIC JASON N Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −13,281 | 26,561 | ||
| 2019-03-04 | GOREVIC JASON N Chief Executive Officer | Grant or award · Restricted Stock Units | +50,333 | 50,333 | ||
| 2019-03-04 | GOREVIC JASON N Chief Executive Officer | Grant or award · Restricted Stock Units | +27,890 | 27,890 | ||
| 2019-02-19 | GOREVIC JASON N Chief Executive Officer | Exercise or conversion | +28,156 | $1.07 | $30K | 631,875 |
Page 121 of 134 · 2,672 trades